A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.
暂无分享,去创建一个
R Kreutz | K Lindpaintner | M. Pfeffer | F. Grodstein | J. Buring | M. Stampfer | C. Hennekens | K. Lindpaintner | R. Kreutz | F. LaMotte | M A Pfeffer | M J Stampfer | C H Hennekens | F Grodstein | M. Pfeffer | F LaMotte | J Buring | J. Buring | Julie E. Buring
[1] G. Lamas,et al. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. , 1994, Circulation.
[2] P Corvol,et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[3] T. Ogihara,et al. A potent genetic risk factor for restenosis , 1993, Nature Genetics.
[4] M. B. Perryman,et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy , 1993, The Lancet.
[5] A. Marian,et al. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death , 1993, The Lancet.
[6] W. Willett,et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.
[7] M. Brown,et al. A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.
[8] D. Ganten,et al. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. , 1993, Journal of molecular and cellular cardiology.
[9] B. Pitt,et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.
[10] F. Cambien,et al. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. , 1994, The Quarterly journal of medicine.
[11] H. Schunkert,et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.
[12] S. Britton,et al. Effects of angiotensin I and angiotensin II on hindlimb and coronary vascular resistance. , 1973, The American journal of physiology.
[13] L. Tiret,et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. , 1992, American journal of human genetics.
[14] K. Sell,et al. Mistyping ACE heterozygotes. , 1993, PCR methods and applications.
[15] Philippe Amouyel,et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.
[16] L. Jorde,et al. Relation between family history of coronary artery disease and coronary risk variables. , 1988, The American journal of cardiology.
[17] O. Costerousse,et al. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. , 1993, The Biochemical journal.
[18] F. Magrini,et al. Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve. , 1988, The American journal of medicine.
[19] D. Underwood,et al. Symptomatic coronary artery disease in patients aged 21 to 30 years. , 1985, The American journal of cardiology.
[20] C. Johnston,et al. INCREASED CARDIAC ANGIOTENSIN‐CONVERTING ENZYME IN RATS WITH CHRONIC HEART FAILURE , 1990, Clinical and experimental pharmacology & physiology.
[21] P. Froguel,et al. Genetic associations with human longevity at the APOE and ACE loci , 1994, Nature Genetics.
[22] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[23] D. Arveiler,et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction , 1993, The Lancet.
[24] E. Gilpin,et al. Myocardial infarction in young patients: an analysis by age subsets. , 1986, Circulation.
[25] F. Cambien,et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Erikssen,et al. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and myocardial infarction , 1993, Clinical genetics.
[27] P. Ridker,et al. Stimulation of Plasminogen Activator Inhibitor In Vivo by Infusion of Angiotensin II Evidence of a Potential Interaction Between the Renin‐Angiotensin System and Fibrinolytic Function , 1993, Circulation.
[28] F. Soubrier,et al. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. , 1991, The Journal of biological chemistry.
[29] F. Eberli,et al. Exacerbation of ischemic dysfunction by angiotensin II in red cell-perfused rabbit hearts. Effects on coronary flow, contractility, and high-energy phosphate metabolism. , 1992, The Journal of clinical investigation.
[30] J. Hyams,et al. Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis. , 1985, The Journal of clinical investigation.
[31] J. Erikssen,et al. Insertion /deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and parental history of myocardial infarction , 1993, Clinical genetics.
[32] B Herman,et al. Multivariate logistic analysis of risk factors for stroke in Tilburg, The Netherlands. , 1983, American journal of epidemiology.
[33] B. Rosner,et al. Analytic methods in matched pair epidemiological studies. , 1978, International journal of epidemiology.
[34] P Corvol,et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.
[35] F. Soubrier,et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). , 1992, Nucleic acids research.
[36] H. Schunkert,et al. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. , 1991, Circulation research.